The most recent listing of current clinical trials for head and neck cancer — including head and neck and thyroid — appears below. Should you be interested in learning more about any of these clinical trials, please use our Contact Us form.
Site: Head and Neck
(Includes Head and Neck and Thyroid)
| Protocol ID |
|
Title |
|
| RTOG 0514 |
|
Establishment of A Head and Neck Cancer Tissue/ Specimen Bank
Keywords: head and neck cancer |
|
| In-House |
|
A Pilot Study to Evaluate the Impact of Computed Tomograph Perfusion on the Gross Target Volume Definition in Patients with Head and Neck Carcinoma
Keywords: head and neck cancer |
|
| Industry-H&N |
|
Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy other than Surgical Resection Alone for Newly Diagnosed Head and Neck Carcinoma
Keywords: newly diagnosed head and neck carcinoma |
|
| Northwestern Oral Leukoplakia |
|
A Phase I Trial of ALA for Treatment of Oral Leukoplakia
Keywords: Oral Leukoplakia |
|
U of C 14696A
Also in endocrine |
|
Phase II Trial of Sunitinib (SU11248) in Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers and Medullary Thyroid Cancers
Keywords: unresectable differentiated thyroid cancers and medullary thyroid cancers |
|
| RTOG 0619 |
|
A Randomized Phase II Trial of Chemoradiotherapy v. Chemoradiotherapy and Vandetanib for High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck
Keywords: High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck |
|
| U of C 16691B |
|
Phase II Trial of Dasatinib (BMS 354825) for Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and Non-Adenoid Cystic Malignant Salivary Tumors
Keywords: Recurrent or Metastatic c-KIT Expressing Adenoid Cystic Carcinoma and Non-Adenoid Cystic Malignant Salivary Tumors |
|